Welcome to Specialised Therapeutics

SE Asia
+65 3158 9940
1300 798 820
New Zealand
+64 9801 0299

Home
About
Products
Pipeline
Partnering
News and Resources
Orders
Contact us

Home
About
Products
Pipeline
Partnering
News and Resources
Orders
Contact us

RxPONDER: Medical Oncologist Dr Richard de Boer

Home
News Archive
RxPONDER: Medical Oncologist Dr Richard de Boer

Medical oncologist Dr Richard de Boer discusses interim results from the Oncotype DX RxPONDER study, presented at the 2020 San Antonio Breast Cancer Symposium. Click on the video banner above to watch the video.

Share Now

Share This Post

Categories

ST Patients Magazines

Recent News

Building from a Solid Foundation:...

February 15, 2024

Patient Experience – Small Cell...

November 2, 2023

Specialised Therapeutics Signs Exclusive License...

October 13, 2023

Keyword

Australia axatilimab breast cancer cholangiocarcinoma distributor GIST HER2+ HR+ Hypoparathyroidism leiomyosarcoma liposarcoma logistics lurbinectedin marinescience nerlynx New Zealand Niktimvo oncology pbs Pemigatinib pharma Philippines qinlock retifanlimab Sarcoma Singapore small cell lung cancer softtissuesarcoma Tafasitamab trabectedin Yondelis Yorvipath Zepzelca Zynyz

For more information about this article, please send an email to:

E: communications@stbiopharma.com

With the highest professional and ethical standards, we commercialise therapies and technologies that uniquely fulfil the unmet needs of our community.

Quick Links

Home
About
Products
Pipeline
News & Resources
Orders
Contact us

Latest News

Specialised Therapeutics Expands Partnership with Incyte to Include Two Additional Therapies for Hard-to-Treat Conditions

June 13, 2025

New Therapy for Children with Growth Hormone Deficiency Approved in Australia

May 30, 2025

Follow Us

Privacy Policy | Terms and Conditions | Site Map | Copyright © 2021 Specialised Therapeutics